Neogen (NEOG) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Neogen (NEOG) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Neogen | 1.98 Bn | 1.82 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -6.76% |
| Nov 30, 2025 | -143.82% |
| Aug 31, 2025 | 105.94% |
| May 31, 2025 | -5,516.92% |
| Feb 28, 2025 | 97.61% |
| Nov 30, 2024 | -3,518.70% |
| Aug 31, 2024 | -132.85% |
| May 31, 2024 | -167.80% |
| Feb 29, 2024 | 42.01% |
| Nov 30, 2023 | -332.00% |
| Aug 31, 2023 | -73.03% |
| May 31, 2023 | -31.97% |
| Feb 28, 2023 | 119.57% |
| Nov 30, 2022 | -903.24% |
| Aug 31, 2022 | -65.18% |
| May 31, 2022 | 174.83% |
| Feb 28, 2022 | -49.73% |
| Nov 30, 2021 | -36.59% |
| Aug 31, 2021 | 8.36% |
| May 31, 2021 | 17.81% |